Apyx Medical (APYX) Total Current Liabilities (2010 - 2026)

Apyx Medical (APYX) has reported Total Current Liabilities for 17 consecutive years, with $9.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities fell 11.47% year-over-year to $9.4 million; the trailing twelve-month figure through Jun 2026 stood at $9.4 million (down 11.47% YoY), and the FY2025 full-year result was $11.7 million, up 9.13% from the prior year.
• Total Current Liabilities fell to $9.4 million in Q2 2026 per APYX's latest filing, from $9.4 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $19.0 million in Q2 2023 and bottomed at $9.4 million in Q2 2026.
• Historically, Total Current Liabilities has averaged $11.6 million across 5 years, with a median of $10.8 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities surged 67.63% in 2023, then slumped 44.09% in 2024.
• Over 5 years, Total Current Liabilities stood at $11.8 million in 2022, then climbed by 7.51% to $12.7 million in 2023, then dropped by 15.85% to $10.7 million in 2024, then rose by 9.13% to $11.7 million in 2025, then declined by 20.05% to $9.4 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $9.4 million, $9.4 million, and $11.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.